ArticleCancer biomarkers : section A of Disease markers2020

Utility of urinary ctDNA to monitoring minimal residual disease in early breast cancer patients.

Gege Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.